Proposed LCDs - Published for Review and Comments
The following seven proposed Local Coverage Determinations (LCDs) have been published for review and comments for contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, and NMI), and 01312 (NV).
|Medicare Coverage Database Number||LCD Title|
|DL37822, DA57773||MolDX: Breast Cancer Index (BCI) Gene Expression Test|
|DL37295, DA57607||MolDX: EndoPredict Breast Cancer Gene Expression Test|
|DL38629, DA58168||MolDX: Liquid Biopsies for Solid Organ Transplantation|
|DL38643, DA58183||MolDX: Phenotypic Biomarker Detection in Circulating Tumor Cells|
|DL38647, DA58181||MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer|
|DL38625, DA58162||Lab: Urine Drug Testing|
|DL34228, DA56572||Percutaneous Vertebral Augmentation (PVA) for Osteoporotic Vertebral Compression Fracture (VCF)|
Comment Period: May 28, 2020 - July 12, 2020
View the CMS MCD to access Proposed LCDs not released to final LCDs.
Providers may address details for comment submission. When sending comments, reference the specific policy to which they are related. See the Proposed LCDs webpage for email and mail specifics.
Last Updated May 21, 2020